Lawsuit charges weigh on Bayer profits again
FRANKFURT, Germany (AP) — Charges for lawsuits over its birth control pills weighed on Bayer AG's earnings once again during the fourth quarter of 2012.
The German company said Thursday it made a net profit of €374 million ($490 million) during the period, compared with €397 million the previous year.
The company booked €455 million in charges during the quarter due to current or anticipated lawsuits in the United States over claims of injuries from blood clots associated with its oral contraceptives.
The profit fall masked a 7.3 percent rise in sales to €9.86 billion.
For the full year, net income declined 1 percent to €2.45 billion while sales rose 8.8 percent to €39.8 billion.
Aside from the problems with the contraceptives, the company said its business was doing well, with sales rising across the three basic divisions: prescription and over-the-counter drugs, farm chemicals and seeds, and synthetic materials such as polyurethanes, adhesives and coatings.
Excluding the lawsuit expenses, earnings before interest, taxes and other financial factors rose 9 percent to €8.24 billion.
Bayer has said it will raise its dividend for 2012 to €1.90 per share from €1.65 amid optimism over the coming year. It forecast a percentage increase in operating earnings in the mid-single digit range.
Bayer shares rose 2.6 percent to €75.71 in morning trading in Europe.
News Photo Galleriesview all
- 92690Oklahoma tornadoes: The 'Big Dog,' the little boy and the hug that triumphs over tragedy
- 17105OKC Thunder: Kevin Durant tours Moore, meets with residents
- 12852Oklahoma tornadoes: ‘All I could do was sit there and hold her'
- 8967Oklahoma tornadoes: Love for Oklahoma generates big donation
- 8623Line of storms brings flash floods to Oklahoma City area
- 8590How to help tornado victims
- 8406Oklahoma tornado: Names of dead released; missing individuals located